# Rapid Therapeutic Science Laboratories, Inc. (RTSL)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/RTSL/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2024 | $ 0 | $ -36.3K | N/A | $ 3.45M | $ -3.08M |
| 2023 | $ 0 | $ 690.1K | $ -280.7K | $ 3.79M | $ -2.74M |
| 2022 | $ 0 | $ -4.06M | $ -1.73M | $ 3.83M | $ -3.14M |
| 2021 | $ 635 | $ -3.41M | $ -2.97M | $ 1.99M | $ -1.38M |
| 2020 | $ 178.4K | $ -1.93M | $ -1.45M | $ 705.6K | $ -494.4K |
| 2019 | $ 0 | $ -488.9K | $ -74.2K | $ 1.22M | $ -1.23M |
| 2018 | $ 0 | $ -3.72M | $ -275.4K | $ 2.94M | $ -3.11M |
| 2017 | $ 0 | $ -34.3K | $ -34.3K | $ 0 | $ 5.4K |
| 2016 | $ 0 | $ -22.6K | $ -21.5K | $ 0 | $ -14.1K |
| 2015 | $ 0 | $ -14.0K | $ -14.0K | $ 0 | $ 2.3K |
| 2014 | $ 0 | $ -23.4K | $ -12.5K | $ 0 | $ 12.2K |
| 2013 | $ 0 | $ -18.8K | $ -16.6K | $ 0 | $ 28.8K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.12 |
| Liabilities / Eq | -1.31 |
| Current Ratio | 0.04 |

## Other views

- [Metrics](https://sponda.capital/en/RTSL.md)
- [Charts](https://sponda.capital/en/RTSL/charts.md)
- [Compare](https://sponda.capital/en/RTSL/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-28.